The agglutinin response to whole-cell and acellular pertussis vaccines is Bordetella pertussis-strain dependent

Dean A Blumberg, E. Pineda, J. D. Cherry, A. Caruso, J. V. Scott

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective. - To determine the significance of the Bordetella pertussis strain used as the antigen in the agglutinin assay for the evaluation of pertussis vaccines. Design. - Randomized, double-blind study. Setting. - Health maintenance organization clinics, primary care clinic at a referral hospital, and private practices in Los Angeles County, California. Participants. - Forty healthy infants. Selection Procedures. - Convenience sample. Interventions. - Twenty infants received whole-cell pertussis- component diphtheria-tetanus-pertussis vaccine (DTP), and 70 infants received acellular pertussis-component diphtheria-tetanus-pertussis vaccine (APDT) at ages 2, 4, and 6 months. Measurements. - The agglutinin assay was performed using three separate B pertussis strain preparations: (1) strains 130 and 138 in equal quantities, the constituents of the DTP vaccine, (2) strain 460, and (3) strain Tohama, the constituent of the APDT vaccine. Results. - The agglutinin titers were highly strain dependent; in both groups of vaccinees at both ages the Tohama values were highest, followed by strain 460 and then strains 130/138. The vaccine groups had comparable titers at age 2 months regardless of the assay antigen used. However, at age 7 months, after three immunizations, the DTP group geometric mean titer was more than 10 times greater than that of the APDT group using strains 130/138, but only 2.6 times higher using strain 460 and almost equivalent using Tohama strain. Conclusion. - Vaccine group agglutinin value comparisons strongly depend on assay antigens used.

Original languageEnglish (US)
Pages (from-to)1148-1150
Number of pages3
JournalAmerican Journal of Diseases of Children
Volume146
Issue number10
StatePublished - 1992
Externally publishedYes

Fingerprint

Diphtheria-Tetanus-Pertussis Vaccine
Acellular Vaccines
Pertussis Vaccine
Bordetella pertussis
Agglutinins
Whooping Cough
Vaccines
Antigens
Los Angeles
Health Maintenance Organizations
Private Practice
Cellular Structures
Double-Blind Method
Immunization
Primary Health Care
Referral and Consultation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

The agglutinin response to whole-cell and acellular pertussis vaccines is Bordetella pertussis-strain dependent. / Blumberg, Dean A; Pineda, E.; Cherry, J. D.; Caruso, A.; Scott, J. V.

In: American Journal of Diseases of Children, Vol. 146, No. 10, 1992, p. 1148-1150.

Research output: Contribution to journalArticle

@article{c7e769710ea04010bf3aba293e8f244a,
title = "The agglutinin response to whole-cell and acellular pertussis vaccines is Bordetella pertussis-strain dependent",
abstract = "Objective. - To determine the significance of the Bordetella pertussis strain used as the antigen in the agglutinin assay for the evaluation of pertussis vaccines. Design. - Randomized, double-blind study. Setting. - Health maintenance organization clinics, primary care clinic at a referral hospital, and private practices in Los Angeles County, California. Participants. - Forty healthy infants. Selection Procedures. - Convenience sample. Interventions. - Twenty infants received whole-cell pertussis- component diphtheria-tetanus-pertussis vaccine (DTP), and 70 infants received acellular pertussis-component diphtheria-tetanus-pertussis vaccine (APDT) at ages 2, 4, and 6 months. Measurements. - The agglutinin assay was performed using three separate B pertussis strain preparations: (1) strains 130 and 138 in equal quantities, the constituents of the DTP vaccine, (2) strain 460, and (3) strain Tohama, the constituent of the APDT vaccine. Results. - The agglutinin titers were highly strain dependent; in both groups of vaccinees at both ages the Tohama values were highest, followed by strain 460 and then strains 130/138. The vaccine groups had comparable titers at age 2 months regardless of the assay antigen used. However, at age 7 months, after three immunizations, the DTP group geometric mean titer was more than 10 times greater than that of the APDT group using strains 130/138, but only 2.6 times higher using strain 460 and almost equivalent using Tohama strain. Conclusion. - Vaccine group agglutinin value comparisons strongly depend on assay antigens used.",
author = "Blumberg, {Dean A} and E. Pineda and Cherry, {J. D.} and A. Caruso and Scott, {J. V.}",
year = "1992",
language = "English (US)",
volume = "146",
pages = "1148--1150",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "10",

}

TY - JOUR

T1 - The agglutinin response to whole-cell and acellular pertussis vaccines is Bordetella pertussis-strain dependent

AU - Blumberg, Dean A

AU - Pineda, E.

AU - Cherry, J. D.

AU - Caruso, A.

AU - Scott, J. V.

PY - 1992

Y1 - 1992

N2 - Objective. - To determine the significance of the Bordetella pertussis strain used as the antigen in the agglutinin assay for the evaluation of pertussis vaccines. Design. - Randomized, double-blind study. Setting. - Health maintenance organization clinics, primary care clinic at a referral hospital, and private practices in Los Angeles County, California. Participants. - Forty healthy infants. Selection Procedures. - Convenience sample. Interventions. - Twenty infants received whole-cell pertussis- component diphtheria-tetanus-pertussis vaccine (DTP), and 70 infants received acellular pertussis-component diphtheria-tetanus-pertussis vaccine (APDT) at ages 2, 4, and 6 months. Measurements. - The agglutinin assay was performed using three separate B pertussis strain preparations: (1) strains 130 and 138 in equal quantities, the constituents of the DTP vaccine, (2) strain 460, and (3) strain Tohama, the constituent of the APDT vaccine. Results. - The agglutinin titers were highly strain dependent; in both groups of vaccinees at both ages the Tohama values were highest, followed by strain 460 and then strains 130/138. The vaccine groups had comparable titers at age 2 months regardless of the assay antigen used. However, at age 7 months, after three immunizations, the DTP group geometric mean titer was more than 10 times greater than that of the APDT group using strains 130/138, but only 2.6 times higher using strain 460 and almost equivalent using Tohama strain. Conclusion. - Vaccine group agglutinin value comparisons strongly depend on assay antigens used.

AB - Objective. - To determine the significance of the Bordetella pertussis strain used as the antigen in the agglutinin assay for the evaluation of pertussis vaccines. Design. - Randomized, double-blind study. Setting. - Health maintenance organization clinics, primary care clinic at a referral hospital, and private practices in Los Angeles County, California. Participants. - Forty healthy infants. Selection Procedures. - Convenience sample. Interventions. - Twenty infants received whole-cell pertussis- component diphtheria-tetanus-pertussis vaccine (DTP), and 70 infants received acellular pertussis-component diphtheria-tetanus-pertussis vaccine (APDT) at ages 2, 4, and 6 months. Measurements. - The agglutinin assay was performed using three separate B pertussis strain preparations: (1) strains 130 and 138 in equal quantities, the constituents of the DTP vaccine, (2) strain 460, and (3) strain Tohama, the constituent of the APDT vaccine. Results. - The agglutinin titers were highly strain dependent; in both groups of vaccinees at both ages the Tohama values were highest, followed by strain 460 and then strains 130/138. The vaccine groups had comparable titers at age 2 months regardless of the assay antigen used. However, at age 7 months, after three immunizations, the DTP group geometric mean titer was more than 10 times greater than that of the APDT group using strains 130/138, but only 2.6 times higher using strain 460 and almost equivalent using Tohama strain. Conclusion. - Vaccine group agglutinin value comparisons strongly depend on assay antigens used.

UR - http://www.scopus.com/inward/record.url?scp=0026666720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026666720&partnerID=8YFLogxK

M3 - Article

C2 - 1415040

AN - SCOPUS:0026666720

VL - 146

SP - 1148

EP - 1150

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 10

ER -